Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001769029-19-000001
Filing Date
2019-02-27
Accepted
2019-02-27 17:09:44
Documents
1
Effectiveness Date
2019-02-27
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6657
  Complete submission text file 0001769029-19-000001.txt   7720
Mailing Address 405 WALTHAM STREET SUITE 353 LEXINGTON MA 02421
Business Address 405 WALTHAM STREET SUITE 353 LEXINGTON MA 02421 7812667297
Abfero Pharmaceuticals, Inc. (Filer) CIK: 0001769029 (see all company filings)

EIN.: 811705490 | State of Incorp.: MA | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-333743 | Film No.: 19638737